Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALLO
DCTH
Add up to 3 more stocks
ALLO
Allogene Therapeutics, Inc.
-4.01%
$1.44-0.06Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$496.99M
52W Range
$1.04 - $4.46
DCTH
Delcath Systems, Inc.
-2.39%
$15.49-0.38Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$534.74M
52W Range
$8.12 - $17.42
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 1191.54 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.14 | 4.41 |
| P/S Ratio | 107.11 | 5.60 |
| P/FCF Ratio | N/A | 30.54 |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 87.0% |
| Operating Margin | 0.0% | -1.9% |
| Net Margin | -3566.7% | 0.6% |
| ROE | -37.9% | 0.4% |
| ROA | -30.1% | 0.4% |
| ROIC | -34.8% | -0.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 10.72 | 9.83 |
| Quick Ratio | 10.72 | 8.95 |
| Debt/Equity | 0.16 | 0.02 |
| Interest Coverage | -192.50 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.